Pharma-Bio Serv, Inc.
PBSV · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,963,083 | $2,417 | $2,471 | $2,333 |
| % Growth | 81,118.3% | -2.2% | 5.9% | – |
| Cost of Goods Sold | $1,388,821 | $1,598 | $1,703 | $1,607 |
| Gross Profit | $574,262 | $819 | $768 | $727 |
| % Margin | 29.3% | 33.9% | 31.1% | 31.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $888,139 | $917 | $860 | $881 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $888,139 | $917 | $860 | $881 |
| Operating Income | -$313,877 | -$98 | -$92 | -$154 |
| % Margin | -16% | -4.1% | -3.7% | -6.6% |
| Other Income/Exp. Net | $104,848 | $199 | $102 | $139 |
| Pre-Tax Income | -$209,029 | $101 | $10 | -$15 |
| Tax Expense | -$5 | $6 | $1 | -$31 |
| Net Income | -$204 | $95 | $9 | $16 |
| % Margin | -0% | 3.9% | 0.3% | 0.7% |
| EPS | -0.009 | 0.004 | 0.37 | 0.035 |
| % Growth | -311.9% | -98.9% | 969.4% | – |
| EPS Diluted | -0.009 | 0.004 | 0.37 | 0.035 |
| Weighted Avg Shares Out | 22,927 | 22,934 | 22,958 | 22,966 |
| Weighted Avg Shares Out Dil | 22,938 | 22,944 | 22,961 | 22,974 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $131 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $58 | $61 | $51 | $47 |
| EBITDA | -$151 | -$38 | -$41 | -$108 |
| % Margin | -0% | -1.6% | -1.7% | -4.6% |